Stock Events

Stock Events

Spyre Therapeutics (3920.F) Q1 2025 Earnings

27FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-1.26

-1.09

-0.93

-0.76

Details

Expected EPS

-0.9482683776

Actual EPS

-0.778896

Surprise EPS

0.17

Surprise Percent

+17.86%

Description

Spyre Therapeutics (3920.F) has reported earnings of -0.778896 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.